Malin Corporation (MLC.I, MLC ID)

  • 111.4
  • 18.9
  • 89.8

    Closing Price (c): 590.0

  • RATING 29/09/15


Company Profile

Malin is an Irish business headquartered and domiciled in Dublin. The group aims to create shareholder value through the application of long-term capital and operational expertise to private, pre-IPO, pre-trade sale operating businesses in dynamic and fast growing segments of the healthcare industry. Malin has a focus on innovative businesses, underpinned by exceptional science, with a proven, sustainable business model. Malin has invested approximately EUR380m across a diverse portfolio of investee companies since its IPO in 2015. The company has identified four priority assets in particular that hold the highest returns potential. These priority assets are developing therapies for high value healthcare markets and are differentiated across product type and therapeutic area. Malin will provide substantive newsflow as the portfolio assets continue to evolve, including milestones that have the potential to create shareholder growth.

Major Shareholders%
ODriscoll Sean10.2